Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review.
Fiche publication
Date publication
mai 2020
Journal
Seminars in oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr THIERY-VUILLEMIN Antoine, Dr MOUILLET Guillaume
Tous les auteurs :
Klajer E, Garnier L, Goujon M, Schlurmann-Constans F, Mery B, Nguyen Tan Hon T, Mouillet G, Calcagno F, Thiery-Vuillemin A
Lien Pubmed
Résumé
Patients with severe renal impairment or undergoing hemodialysis are usually excluded from clinical trials. Available data regarding safety and activity of systemic therapies (ST) in hemodialyzed patients are scarce.
Mots clés
Dialysis, Immunotherapy, Pharmacokinetic, Systemic therapies
Référence
Semin. Oncol.. 2020 May 26;: